ID   KPCD_HUMAN              Reviewed;         676 AA.
AC   Q05655; B2R834; Q15144; Q86XJ6;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   05-OCT-2010, entry version 123.
DE   RecName: Full=Protein kinase C delta type;
DE            EC=2.7.11.13;
DE   AltName: Full=nPKC-delta;
GN   Name=PRKCD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS SER-375 AND MET-593.
RC   TISSUE=Liver;
RX   MEDLINE=93363635; PubMed=8357834; DOI=10.1016/0167-4781(93)90111-P;
RA   Aris J.P., Basta P.V., Holmes W.D., Ballas L.M., Moomaw C.,
RA   Rankl N.B., Blobel G., Loomis C.R., Burns D.J.;
RT   "Molecular and biochemical characterization of a recombinant human
RT   PKC-delta family member.";
RL   Biochim. Biophys. Acta 1174:171-181(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-365.
RC   TISSUE=Hippocampus;
RA   Hug H.;
RT   "Partial cDNA Sequence of human protein kinase C delta.";
RL   Submitted (MAR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 51-676.
RX   MEDLINE=98087154; PubMed=9427282;
RX   DOI=10.1046/j.1365-2443.1997.1470346.x;
RA   Nomoto S., Watanabe Y., Ninomiya-Tsuji J., Yang L.-X., Kikuchi K.,
RA   Hagiwara M., Hidaka H., Matsumoto K., Irie K.;
RT   "Functional analyses of mammalian protein kinase C isozymes in budding
RT   yeast and mammalian fibroblasts.";
RL   Genes Cells 2:601-614(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 432-533, AND VARIANT VAL-494.
RX   MEDLINE=95080426; PubMed=7988719; DOI=10.1016/0014-5793(94)01202-4;
RA   Palmer R.H., Ridden J., Parker P.J.;
RT   "Identification of multiple, novel, protein kinase C-related gene
RT   products.";
RL   FEBS Lett. 356:5-8(1994).
RN   [8]
RP   INTERACTION WITH MUC1, AND FUNCTION.
RX   PubMed=11877440; DOI=10.1074/jbc.M200436200;
RA   Ren J., Li Y., Kufe D.;
RT   "Protein kinase C delta regulates function of the DF3/MUC1 carcinoma
RT   antigen in beta-catenin signaling.";
RL   J. Biol. Chem. 277:17616-17622(2002).
RN   [9]
RP   INTERACTION WITH RAD9A.
RX   PubMed=12628935; DOI=10.1093/emboj/cdg134;
RA   Yoshida K., Wang H.-G., Miki Y., Kufe D.;
RT   "Protein kinase Cdelta is responsible for constitutive and DNA damage-
RT   induced phosphorylation of Rad9.";
RL   EMBO J. 22:1431-1441(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-664, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-313; TYR-334 AND
RP   TYR-374, AND MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-313, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-43; THR-50; SER-299;
RP   SER-302; SER-307; TYR-313; TYR-334; SER-503; SER-647; SER-654; SER-658
RP   AND SER-664, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-302; SER-304;
RP   SER-307 AND SER-664, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-313 AND TYR-374, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-43; THR-218; THR-295;
RP   SER-299; SER-302; SER-304; TYR-313; TYR-334; SER-506; SER-645; SER-647
RP   AND SER-664, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-313 AND SER-664, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-123 IN COMPLEX WITH
RP   PHOSPHOTYROSINE-CONTAINING PEPTIDE, AND INTERACTION WITH CDCP1.
RX   PubMed=15851033; DOI=10.1016/j.cell.2005.02.019;
RA   Benes C.H., Wu N., Elia A.E.H., Dharia T., Cantley L.C., Soltoff S.P.;
RT   "The C2 domain of PKCdelta is a phosphotyrosine binding domain.";
RL   Cell 121:271-280(2005).
RN   [22]
RP   STRUCTURE BY NMR OF 149-218.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the first phorbol esters/diacylglycerol binding
RT   domain of human protein kinase C, delta.";
RL   Submitted (APR-2008) to the PDB data bank.
CC   -!- FUNCTION: This is calcium-independent, phospholipid-dependent,
CC       serine- and threonine-specific enzyme. PKC is activated by
CC       diacylglycerol which in turn phosphorylates a range of cellular
CC       proteins. PKC also serves as the receptor for phorbol esters, a
CC       class of tumor promoters. May play a role in antigen-dependent
CC       control of B-cell function. Phosphorylates MUC1 in the C-terminal
CC       and regulates the interaction between MUC1 and beta-catenin.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Three specific sites; Thr-507 (activation loop
CC       of the kinase domain), Ser-645 (turn motif) and Ser-664
CC       (hydrophobic region), need to be phosphorylated for its full
CC       activation.
CC   -!- SUBUNIT: Interacts with PDK1, RAD9A, CDCP1 and MUC1.
CC   -!- INTERACTION:
CC       P06241:FYN; NbExp=3; IntAct=EBI-704279, EBI-515315;
CC       P17677:GAP43; NbExp=3; IntAct=EBI-704279, EBI-1267511;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Membrane;
CC       Peripheral membrane protein (By similarity).
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type
CC       region 1 (C1A) and 2 (C1B), is the diacylglycerol sensor.
CC   -!- DOMAIN: The C2 domain is a non-calcium binding domain. It binds
CC       proteins containing phosphotyrosine in a sequence-specific manner.
CC   -!- PTM: Phosphorylated on Thr-507, within the activation loop.
CC       Autophosphorylated and/or phosphorylated. Although the Thr-507
CC       phosphorylation occurs it is not a prerequisite for enzymatic
CC       activity (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 C2 domain.
CC   -!- SIMILARITY: Contains 2 phorbol-ester/DAG-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PRKCDID42901ch3p21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L07860; AAA03176.1; -; mRNA.
DR   EMBL; L07861; AAA03175.1; -; mRNA.
DR   EMBL; AK313216; BAG36031.1; -; mRNA.
DR   EMBL; CH471055; EAW65279.1; -; Genomic_DNA.
DR   EMBL; BC043350; AAH43350.1; -; mRNA.
DR   EMBL; Z22521; CAA80249.1; -; mRNA.
DR   EMBL; D10495; BAA01381.1; -; mRNA.
DR   IPI; IPI00329236; -.
DR   PIR; S35704; S35704.
DR   RefSeq; NP_006245.2; -.
DR   RefSeq; NP_997704.1; -.
DR   UniGene; Hs.155342; -.
DR   PDB; 1YRK; X-ray; 1.70 A; A=1-123.
DR   PDB; 2YUU; NMR; -; A=149-218.
DR   PDBsum; 1YRK; -.
DR   PDBsum; 2YUU; -.
DR   ProteinModelPortal; Q05655; -.
DR   SMR; Q05655; 155-262, 227-283, 346-668.
DR   DIP; DIP-29954N; -.
DR   IntAct; Q05655; 12.
DR   MINT; MINT-1346366; -.
DR   STRING; Q05655; -.
DR   PhosphoSite; Q05655; -.
DR   PRIDE; Q05655; -.
DR   Ensembl; ENST00000330452; ENSP00000331602; ENSG00000163932.
DR   Ensembl; ENST00000394729; ENSP00000378217; ENSG00000163932.
DR   GeneID; 5580; -.
DR   KEGG; hsa:5580; -.
DR   CTD; 5580; -.
DR   GeneCards; GC03P053170; -.
DR   H-InvDB; HIX0024312; -.
DR   HGNC; HGNC:9399; PRKCD.
DR   HPA; CAB010469; -.
DR   HPA; CAB013225; -.
DR   HPA; HPA001863; -.
DR   HPA; HPA001890; -.
DR   MIM; 176977; gene.
DR   PharmGKB; PA33763; -.
DR   eggNOG; prNOG17515; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q05655; -.
DR   OMA; RCTGTAT; -.
DR   OrthoDB; EOG95F081; -.
DR   PhylomeDB; Q05655; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; alphasynuclein_pathway; Alpha-synuclein signaling.
DR   Pathway_Interaction_DB; ceramidepathway; Ceramide signaling pathway.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; hedgehog_glipathway; Hedgehog signaling events mediated by Gli proteins.
DR   Pathway_Interaction_DB; ifngpathway; IFN-gamma pathway.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; il6_7pathway; IL6-mediated signaling events.
DR   Pathway_Interaction_DB; lysophospholipid_pathway; LPA receptor mediated events.
DR   Pathway_Interaction_DB; pdgfrbpathway; PDGFR-beta signaling pathway.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; syndecan_2_pathway; Syndecan-2-mediated signaling events.
DR   Pathway_Interaction_DB; syndecan_4_pathway; Syndecan-4-mediated signaling events.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Pathway_Interaction_DB; mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_15295; Opioid Signalling.
DR   Reactome; REACT_578; Apoptosis.
DR   PMAP-CutDB; Q05655; -.
DR   ArrayExpress; Q05655; -.
DR   Bgee; Q05655; -.
DR   CleanEx; HS_PRKCD; -.
DR   Genevestigator; Q05655; -.
DR   GermOnline; ENSG00000163932; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004699; F:calcium-independent protein kinase C activity; TAS:BHF-UCL.
DR   GO; GO:0008047; F:enzyme activator activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0043560; F:insulin receptor substrate binding; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor sig...; TAS:BHF-UCL.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine ph...; ISS:BHF-UCL.
DR   GO; GO:0032091; P:negative regulation of protein binding; TAS:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; NAS:UniProtKB.
DR   GO; GO:0010469; P:regulation of receptor activity; TAS:BHF-UCL.
DR   GO; GO:0010149; P:senescence; IMP:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_Ca-dep.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; FALSE_NEG.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Repeat; Serine/threonine-protein kinase; Transferase;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    676       Protein kinase C delta type.
FT                                /FTId=PRO_0000055694.
FT   DOMAIN        1     90       C2.
FT   DOMAIN      349    603       Protein kinase.
FT   DOMAIN      604    675       AGC-kinase C-terminal.
FT   ZN_FING     158    208       Phorbol-ester/DAG-type 1.
FT   ZN_FING     230    280       Phorbol-ester/DAG-type 2.
FT   NP_BIND     355    363       ATP (By similarity).
FT   ACT_SITE    473    473       Proton acceptor (By similarity).
FT   BINDING     378    378       ATP (By similarity).
FT   SITE         48     48       Interaction with phosphotyrosine-
FT                                containing peptide.
FT   SITE         62     62       Interaction with phosphotyrosine-
FT                                containing peptide.
FT   SITE         67     67       Interaction with phosphotyrosine-
FT                                containing peptide.
FT   SITE        123    123       Interaction with phosphotyrosine-
FT                                containing peptide.
FT   MOD_RES      43     43       Phosphothreonine.
FT   MOD_RES      50     50       Phosphothreonine.
FT   MOD_RES     130    130       Phosphoserine.
FT   MOD_RES     218    218       Phosphothreonine.
FT   MOD_RES     295    295       Phosphothreonine.
FT   MOD_RES     299    299       Phosphoserine.
FT   MOD_RES     302    302       Phosphoserine.
FT   MOD_RES     304    304       Phosphoserine.
FT   MOD_RES     307    307       Phosphoserine.
FT   MOD_RES     313    313       Phosphotyrosine.
FT   MOD_RES     331    331       Phosphoserine.
FT   MOD_RES     334    334       Phosphotyrosine.
FT   MOD_RES     374    374       Phosphotyrosine.
FT   MOD_RES     503    503       Phosphoserine.
FT   MOD_RES     506    506       Phosphoserine.
FT   MOD_RES     507    507       Phosphothreonine; by PDPK1 (By
FT                                similarity).
FT   MOD_RES     645    645       Phosphoserine.
FT   MOD_RES     647    647       Phosphoserine.
FT   MOD_RES     654    654       Phosphoserine.
FT   MOD_RES     658    658       Phosphoserine.
FT   MOD_RES     664    664       Phosphoserine.
FT   VARIANT     348    348       N -> S (in dbSNP:rs33911937).
FT                                /FTId=VAR_035347.
FT   VARIANT     375    375       F -> S (in dbSNP:rs1056998).
FT                                /FTId=VAR_006175.
FT   VARIANT     410    410       L -> F (in dbSNP:rs34502209).
FT                                /FTId=VAR_035348.
FT   VARIANT     483    483       R -> W (in dbSNP:rs35891605).
FT                                /FTId=VAR_046009.
FT   VARIANT     494    494       M -> V.
FT                                /FTId=VAR_020610.
FT   VARIANT     593    593       V -> M.
FT                                /FTId=VAR_006176.
FT   CONFLICT    524    524       K -> R (in Ref. 2; BAG36031).
FT   CONFLICT    533    533       S -> A (in Ref. 7).
FT   STRAND        1     13
FT   STRAND       20     23
FT   STRAND       27     38
FT   STRAND       41     45
FT   STRAND       58     62
FT   STRAND       68     76
FT   STRAND       79     87
FT   HELIX        88     96
FT   TURN         97    100
FT   STRAND      101    107
FT   STRAND      109    111
SQ   SEQUENCE   676 AA;  77505 MW;  013F4314A2EE331A CRC64;
     MAPFLRIAFN SYELGSLQAE DEANQPFCAV KMKEALSTER GKTLVQKKPT MYPEWKSTFD
     AHIYEGRVIQ IVLMRAAEEP VSEVTVGVSV LAERCKKNNG KAEFWLDLQP QAKVLMSVQY
     FLEDVDCKQS MRSEDEAKFP TMNRRGAIKQ AKIHYIKNHE FIATFFGQPT FCSVCKDFVW
     GLNKQGYKCR QCNAAIHKKC IDKIIGRCTG TAANSRDTIF QKERFNIDMP HRFKVHNYMS
     PTFCDHCGSL LWGLVKQGLK CEDCGMNVHH KCREKVANLC GINQKLLAEA LNQVTQRASR
     RSDSASSEPV GIYQGFEKKT GVAGEDMQDN SGTYGKIWEG SSKCNINNFI FHKVLGKGSF
     GKVLLGELKG RGEYFAIKAL KKDVVLIDDD VECTMVEKRV LTLAAENPFL THLICTFQTK
     DHLFFVMEFL NGGDLMYHIQ DKGRFELYRA TFYAAEIMCG LQFLHSKGII YRDLKLDNVL
     LDRDGHIKIA DFGMCKENIF GESRASTFCG TPDYIAPEIL QGLKYTFSVD WWSFGVLLYE
     MLIGQSPFHG DDEDELFESI RVDTPHYPRW ITKESKDILE KLFEREPTKR LGVTGNIKIH
     PFFKTINWTL LEKRRLEPPF RPKVKSPRDY SNFDQEFLNE KARLSYSDKN LIDSMDQSAF
     AGFSFVNPKF EHLLED
//
